| CPC H10K 85/342 (2023.02) [C07F 15/0033 (2013.01); C09K 11/06 (2013.01); H05B 33/14 (2013.01); C09K 2211/1007 (2013.01); C09K 2211/1011 (2013.01); C09K 2211/1029 (2013.01); C09K 2211/185 (2013.01); H10K 50/11 (2023.02); H10K 85/622 (2023.02); H10K 85/6576 (2023.02); H10K 2101/10 (2023.02)] | 20 Claims |

|
1. A compound comprising a heteroleptic iridium complex having the formula:
![]() wherein R1, R2, R3, R5, and R6, are independently selected from the group consisting of hydrogen, deuterium, cycloalkyl, deuterated cycloalkyl, alkyl, and deuterated alkyl;
wherein at least one of R1, R2, R3, R5, and R6 is cycloalkyl, deuterated cycloalkyl, alkyl, or deuterated alkyl;
wherein any two adjacent R1, R2, R3, R4, R5, and R6 are optionally linked together to form a ring;
wherein R and R′ represent mono-, di-, tri- or tetra-substitution and are independently selected from the group consisting of hydrogen, deuterium, halide, alkyl, cycloalkyl, heteroalkyl, arylalkyl, alkoxy, aryloxy, amino, silyl, alkenyl, cycloalkenyl, heteroalkenyl, alkynyl, aryl, heteroaryl, acyl, carbonyl, carboxylic acids, ester, nitrile, isonitrile, sulfanyl, sulfinyl, sulfonyl, phosphino, and combinations thereof; and
wherein R2 is not H, R4 is deuterated alkyl, cycloalkyl, or deuterated cycloalkyl, at least one R is not H, D, substituted or unsubstituted aryl, or substituted or unsubstituted heteroaryl, and at least four of R5, R6, and R are H.
|